UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037709
Receipt number R000042960
Scientific Title The offect of Aromatherapy massage for the patients with Schizophrenia
Date of disclosure of the study information 2019/08/18
Last modified on 2019/08/17 02:36:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The offect of Aromatherapy massage for the patients with Schizophrenia

Acronym

The offect of Aromatherapy massage for the patients with Schizophrenia

Scientific Title

The offect of Aromatherapy massage for the patients with Schizophrenia

Scientific Title:Acronym

The offect of Aromatherapy massage for the patients with Schizophrenia

Region

Japan


Condition

Condition

Schizophrenia

Classification by specialty

Psychiatry Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal the Aromatherapy massage for the patients with Schizophrenia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Scale of feeling of relaxation
Salivary amylase

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Aromatherapy massage

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with Schizophrenia during hospitalization

Key exclusion criteria

The people with Allergic reaction by patch test

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Taeko
Middle name
Last name Kumazawa

Organization

National Hospital Organization Simofusa Psychiatric hospital

Division name

Nursing division

Zip code

266-0007

Address

578 , Hetacho , Midori-ku , Chiba-si , Chiba

TEL

043-291-1221

Email

kumazawa.taeko.mg@mail.hosp.go.jp


Public contact

Name of contact person

1st name Taeko
Middle name
Last name Kumazawa

Organization

National Hospital Organization Simofusa Psychiatric hospital

Division name

Nursing division

Zip code

266-0007

Address

578 , Hetacho , Midori-ku , Chiba-si , Chiba

TEL

043-291-1221

Homepage URL


Email

kumazawa.taeko.mg@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Simofusa Psychiatric hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Simofusa Psychiatric hospital

Address

578 , Hetacho , Midori-ku , Chiba-si , Chiba

Tel

043-291-1221

Email

kumazawa.taeko.mg@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人国立病院機構下総精神医療センター(千葉県)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 03 Month 31 Day

Baseline Characteristics

Schizophrenia

Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 08 Month 13 Day

Date of IRB


Anticipated trial start date

2019 Year 08 Month 13 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 17 Day

Last modified on

2019 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042960